- Hulst
- https://gitea.ww3.tw/seymourt888067
-
No patient from the PSPA-nt and PA-nt groups received androgen substitutes, gonadotropin therapy, or pharmacologic castration over the follow-up duration. The flowchart of PA-nt patient inclusion is illustrated in the Supplementary Fig.
- Joined on
2026-04-03
Block a user